ArticleTranslational cancer research2026

Glaucocalyxin A sensitizes ovarian cancer cells to PARP inhibitors by inducing DNA damage.

Lingling Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.